Clinical significance of perineural invasion by prostate cancer

Published Date: 08 Mar 2023

This study examines the clinical impact of unilateral perineural invasion in prostate cancer. How does unilaterality affect long-term oncology outcomes?

Read Full News

Latest News

Nonactionable Mutations on Metastatic Prostate Cancer

Molecular testing for metastatic prostate cancer with next generation sequencing (NGS) is standard for the evaluation for targetable pathogenic variants.

What Drives Early-Onset Colorectal Cancer?

What role do diet, obesity, the microbiome, and screening play in early-onset colorectal cancer? Dr Benjamin Levy and Dr Aasma Shaukat discuss the latest evidence.

PSA-Discordant Progression in Metastatic Prostate Cancer

Rare squamous transformation in metastatic prostate cancer caused disease progression despite suppressed PSA, found only through re-biopsy.

Alcohol's Heart Benefit Was a Statistical Illusion

No dose of alcohol is risk-free, and none protects the heart. It's time to counsel patients on drinking less rather than where the line sits.

A Woman on Ruxolitinib Had TB That Mimicked Metastases

A woman receiving ruxolitinib for polycythemia vera developed disseminated tuberculosis despite a negative IGRA, highlighting the limits of screening.

Pediatric Gastroenterology Faces AI Reality Check

From nutrition screening to IBD monitoring, AI shows promise in pediatric gastroenterology — yet experts stress pediatric validation is essential.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

Molecular testing for metastatic prostate cancer with next generation sequencing (NGS) is standard for the evaluation for targetable pathogenic variants.

What role do diet, obesity, the microbiome, and screening play in early-onset colorectal cancer? Dr Benjamin Levy and Dr Aasma Shaukat discuss the latest evidence.

Rare squamous transformation in metastatic prostate cancer caused disease progression despite suppressed PSA, found only through re-biopsy.

No dose of alcohol is risk-free, and none protects the heart. It's time to counsel patients on drinking less rather than where the line sits.

A woman receiving ruxolitinib for polycythemia vera developed disseminated tuberculosis despite a negative IGRA, highlighting the limits of screening.

From nutrition screening to IBD monitoring, AI shows promise in pediatric gastroenterology — yet experts stress pediatric validation is essential.

News All Time

S1 Episode 4: How Early Is Early Enough to Reverse MASLD?

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

ArteraAI: Current Indications in Prostate Cancer

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

Teen With a Slowly Enlarging Annular Hyperkeratotic Papule

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

Thyroid Surgery: Practical Strategies for Optimal Post-op Care

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

What's Driving Pancreatic Cancer Risk?

From modifiable habits to genetic red flags, here's what raises pancreatic cancer risk, and when to screen for it.

Rapid Genetic Screening May Protect Newborn Hearing

A rapid bedside genetic test may help neonatologists avoid gentamicin-related hearing loss in newborns at the highest risk.

Early Breast Cancer: Time to Act on Molecular Resistance?

In breast cancer, molecular resistance can precede clinical progression, but should it prompt an immediate change in treatment?

Punch Biopsy Techniques Every PCP Should Know

Performing a punch biopsy doesn't have to be daunting. Learn the essential steps every PCP needs to confidently sample, suture, and care for biopsy sites.

Risk Assessment of Thyroid Nodules: A Practical Guide

Most thyroid nodules are benign, but risk stratification matters. Learn how ultrasound, TI-RADS, and postbiopsy tools guide smarter referral decisions.

A PCP’s Guide to Tangential Shave Biopsy

Learn how to perform a tangential shave biopsy with confidence. This step-by-step guide walks PCPs through the essential technique for sampling skin lesions and tumors.

Four Signs You Should Biopsy a Skin Lesion, Not Freeze It

Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.

BRCA Testing Shifts From Late Data to Urgent Priority

BRCA testing now guides urgent treatment decisions as well as family risk assessment, and Spanish experts highlight its implications for PARP inhibitors, oncofertility, liquid biopsy, and exercise.

Wet Age-Related Macular Degeneration Updates From ASRS 2026

Updates in wet AMD from ASRS 2026 include real-world data on anti-VEGF treatment persistence, ELARA data on aflibercept 8 mg, as well as two studies showing reduced injection burden via gene therapy.

Stop Assuming Every Thick, Yellow Nail Is Fungus

Treating toenail fungus without confirming the diagnosis is a common mistake. Here's how to confirm it, treat it, and know what to expect.

Trust Me — I'm a Podcaster

Public trust in institutions has waned but patients trust their personal doctors. Clinicians can be influencers without TikTok or a podcast writes this podcasting cardiologist.

Erythematous Infiltrated Papules and Plaques on the Forehead

A 32-year-old woman presented to the dermatology department with asymptomatic raised, reddish lesions on the right forehead of 5 months’ duration.

Recommended News For You

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

New analysis helps discern benign from malignant thyroid growths

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Recommended Articles For You

Hematopoietic Stem Cell Exhaustion in Blood Disorders 

Cancer Rates on the Rise: What Can We Do to Stop It? 

Exploring the Causes and Treatments of Cysts: A Comprehensive Guide 

Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Understudied mental health challenges among caregivers of cancer patients: A call for targeted support

2.

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

3.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

4.

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

5.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

1.

A Closer Look at the Effects of Sickle Cell on Eyesight

2.

Hematology Services in Remote Regions: Challenges, Innovations, and Clinical Implications

3.

Clinical Pharmacology of Erythroid Maturation Pathway Regulators

4.

Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control

5.

Strategic Practices in Oncology for Specialists

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Understanding Anemia: Causes and Treatment

2.

Navigating the Complexities of Ph Negative ALL - Part VI

3.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

4.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot